Allergan Breast Implant Lawsuits: The Reality

I am Erickatherine. I hold full responsibility for this content, which includes text, images, links, and files. The website administrator and team cannot be held accountable for this content. If there is anything you need to discuss, you can reach out to me via email.

Disclaimer: The domain owner, admin and website staff of Times Square Reporter, had no role in the preparation of this post. Times Square Reporter, does not accept liability for any loss or damages caused by the use of any links, images, texts, files, or products, nor do we endorse any content posted in this website.

Medlegal360 is the number one blogging site for medical-legal resource. Oh! Lawyers, medical doctors, patients, Don’t walk but run you have everything at medlegal360 platform.
Allergan Breast Implant Lawsuits: The Reality
The importance of patients being fully informed about the benefits and drawbacks of medical devices is highlighted by the Allergan breast implant lawsuits. The significant correlation between textured implants and BIA-ALCL should prompt quick research, increased awareness, and changes in medical advice regarding alternative breast implant options.

Allergan Breast Implant Lawsuits: The Reality

Allergan breast implant lawsuits is all about Allergan breast implants causing Breast Implant-Associated Anaplastic Large Cell Lymphoma. Gavin S. Herbert, a pharmacist, founded Allergan Pharmaceuticals in 1948. Initially established as an American multinational pharmaceutical company, Allergan, Inc. focused on medical aesthetics, neurosciences, medical dermatology, urologics, breast augmentation, and ophthalmology.

The outer shell of Allergan breast implants is composed of silicone elastomer, a kind of silicone with elastic qualities akin to those of rubber. Seawater solution, sterile saline, or silicone gel can be used to fill the shells.

In comparison to other textured implants, the Food and Drug Administration announced on July 24, 2019, that it had found evidence connecting Allergan BIOCELL textured breast implants to a higher incidence of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Approximately 85% of BIA-ALCL cases, according to the FDA, have involved recipients of Allergan's BIOCELL® textured implants.

A rare kind of non-Hodgkin's lymphoma that is different from breast cancer is called BIA-ALCL. Since the early 1990s, attempts have been made to gain a deeper understanding of the condition's causes, symptoms, and effects.

The Allergan BIOCELL textured breast implant products covered in the recall are as follows.

                     Natrelle Saline-Filled breast implants

                     Natrelle Silicone-Filled breast implants

                     Natrelle Inspira Silicone-Filled breast implants

                     Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled breast implants

                     Natrelle 133 Plus Tissue Expander

                     Natrelle 133 Tissue Expander with Suture Tabs

Several months after the company's recall, federal lawsuits against Allergan's Natrelle BIOCELL Textured Breast Implants emerged. In December 2019, the U.S. Judicial Panel on Multidistrict Litigation consolidated all federal cases into a New Jersey MDL class action.

Allergan BIOCELL Textured Breast Implant Products Liability Litigation, No. 2:19-md-02921, MDL No. 2921 (D.N.J.) is the multi-district litigation. The MDL, which is pending in the US District Court for the District of New Jersey, brings claims on behalf of American women who were harmed by Allergan's Biocell® Textured Breast Implants for personal injuries, economic damages, and medical monitoring.

What's your reaction?


0 comment

Write the first comment for this!

Facebook Conversations